Interleukin-22: a likely target for treatment of autoimmune diseases
about
Lacrimal gland-derived IL-22 regulates IL-17-mediated ocular mucosal inflammation.Role of interleukin-22 in inflammatory bowel diseaseThe parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr miceT cell subsets and their signature cytokines in autoimmune and inflammatory diseases.Achalasia--An Autoimmune Inflammatory Disease: A Cross-Sectional Study.Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.Performance evaluation of FlowCytomix assays to quantify cytokines in patients with rheumatoid arthritisCigarette smoke inhibits ROCK2 activation in T cells and modulates IL-22 productionInterleukin-22 Secreted by NKp44+ Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis.Inhibition of cytokine response to TLR stimulation and alleviation of collagen-induced arthritis in mice by Schistosoma japonicum peptide SJMHE1.γδ T Cell-Mediated Immune Responses in Disease and TherapyPlasticity of neutrophils reveals modulatory capacity.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.A review on interleukins: The key manipulators in rheumatoid arthritis.Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.Aberrant expression of interleukin-22 and its targeting microRNAs in oral lichen planus: a preliminary study.All of the twos, 22-bingo!Autoimmunity in 2014.Increased circulating Th22 cells in patients with acute gouty arthritis: A CONSORT-compliant article.Cutting edge data in autoimmunity: as presented in the 9th International Congress of Autoimmunity.NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis.MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22.The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults.IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.NK22 Cells in the Uterine Mid-Secretory Endometrium and Peripheral Blood of Women with Recurrent Pregnancy Loss and Unexplained Infertility.The role of IL-22 in the resolution of sterile and nonsterile inflammation.
P2860
Q33870377-C93DF04E-24FF-4EF3-8DC8-5293C7AC040CQ34456769-5C46E0A2-E4CB-47FD-818C-70D7906EB56CQ35538362-E785633C-4AC9-42BE-AB8F-F0EE35F1D99CQ35558638-5A61378E-47F5-4914-9800-5A3A6B9A4732Q35675896-8CFC6BEA-BE84-48DC-8857-49555BC895DEQ36118883-1951F859-84D2-43E1-9F0B-CE46C476761FQ36317874-9CD0F11C-F131-43B5-B80D-8CFDC342CC4DQ36701228-5627D5FC-2FE5-4F0B-BF6F-4757DD1D969BQ37624160-C6A20F82-80FE-49CF-AB33-DB7D4C066F6BQ37662876-D1F3ADE7-CD4C-44E9-BC87-D9AA414ECE85Q38271584-7B07606A-36C0-4E3D-A702-24FB05814AF9Q38537035-FC7F86F4-2334-4AB5-87EE-271F9DB08946Q38799600-BB3597EF-E53C-4275-84FA-AF0A04B6EAFCQ39029629-6006DF8A-5A2A-470D-8732-F30EAF568D09Q39792098-94818474-5096-4808-A40C-319F535E6C4AQ40164851-8BE4D9FD-03F3-4A2B-9B2D-2475F9B3C4D9Q42547437-A76C7EFC-2AB1-4352-A6C6-F80FFCCE2BAEQ42643483-7BF5291C-1C4A-4AB2-954C-E0A2CA56B56EQ45798081-0C80AF17-D7C9-4C16-910F-BFC910709C4EQ45836428-0B7D9033-85B3-494D-81F3-56D1DDF0AB28Q47145348-36B521F6-B068-41AB-BB7D-92067893E262Q49580146-E99D4D01-1CC9-4439-BB78-2E39ECDE7904Q50155916-E637BD37-D16D-4584-BD7A-A6A7670DD6DEQ52911127-05FD80C1-64B9-44C3-8366-6745485D672EQ53652932-29FCBF06-01D3-4AE3-B1A3-CAE88B6E83E3Q54224246-8FBC61A3-1205-4B02-9F9E-26B32C3CC767
P2860
Interleukin-22: a likely target for treatment of autoimmune diseases
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin-22: a likely target for treatment of autoimmune diseases
@en
type
label
Interleukin-22: a likely target for treatment of autoimmune diseases
@en
prefLabel
Interleukin-22: a likely target for treatment of autoimmune diseases
@en
P2860
P1433
P1476
Interleukin-22: a likely target for treatment of autoimmune diseases
@en
P2093
Song Guo Zheng
Xuyan Yang
P2860
P304
P356
10.1016/J.AUTREV.2013.11.008
P577
2014-01-10T00:00:00Z